ABSTRACT
INTRODUCTION
anogels are the cross linked polymers of submicrometer size made up of hydrophilic polymers. They are soluble in water, but have properties different from linear macromolecules of similar molecular weight. Such structures along with their bigger analogues. As a family of nanoscale particulate materials, hydrogel nanoparticles (recently referred as nanogels) have been the point of convergence of considerable amount of efforts devoted to the study of these systems dealing with drug delivery approaches. Interestingly hydrogel nanoparticulate materials would demonstrate the features and characteristics of hydrogels and NPs separately possess at the same time. Therefore it seems that pharmacy world will benefit from both the hydrophilicity, flexibility, versatility, high water absorptivity and biocompatibility of these particles and all the advantages of the nanoparticles, mainly long life span in circulation and the possibility of being actively or passively targeted to the desired bio phase, eg Tumor sites. Different methods have been adopted to prepare nanoparticles of hydrogel consistency. Besides the commonly used synthetic polymers. Active research is focused on the preparation of nanoparticles using naturally occurring hydrophilic polymers. [1, 2] Nanogels are been prepared for the encapsulation of hydrophobic drug so it shows better bioavailability and increase efficacy of the drug. Nanogels acts as the carrier mediated drug delivery system to deliver the drug to the site of action. Nanogels when applied to the skin, even if the gel above gets evaporated from the skin the nanoparticles present gets deep penetrated inside the skin at the site of action and shows the action at the specific site of the skin. [13] N ISSN: 2320-4850
[82] www.ajprd.com/AJPRD Features of Nanogels [3]  Size control: Nanogel size and surface properties can be chemically controlled to limit the rate of clearence by phagocytic cells as well as to enable either passive or active cell targeting. Nanogels must be small enough to traverse capillaries and penetrate tissues through either paracellular or transcellular pathways.  Ease of synthesis: The scalability of laboratory based nanogel development to industrial scale production for clinical markets and the use of "green" approaches to nanogel manufacturing are important considerations for cost and environmental impact.  High encapsulation stability: Drug molecules loaded into the nanogel need to be retained and not to be transported out or leak prematurely while circulating in order to provide maximum therapeutic effects and minimum toxicity or side effects.  Controlled and sustained drug release: Drug transport should occur at the target site, thereby providing both therapeutic efficacy and reduced side effects. Drug loading should be sufficiently high to achieve therapeutic goals.  Response to stimuli: Nanogels are designed to respond to specific stimuli must retained high drug encapsulation efficiency stability while circulating to reach target site and drug should release readily to the appropriate stimulus.  Targetting: Site specific delivery of nanogels carriers can be achieved via either coupling to their surface affinity ligands binding to target determinants or using responsiveness to local factors as above, or via "passive" targeting approaches including extravasation in the pathological sites and retention in the microvasculature.  Low toxicity: The nanogels themselves should be highly biocompatible and free from toxicity, and should be biodegradable with non-toxic degradation products that are readily cleared from the body.
MATERIALS AND METHODS

Materials
Carbopol 934, Propylene glycol, Glycerin and Triethanolamine was a kind of gift sample from Research lab chemicals.
Preformulation study:
Preformulation study is the first step in the rationale development of any pharmaceutical dosage form of a new drug. Preformulation study focuses on those physiochemical properties of the new drug performance and development of an efficacious dosage form. The preformulation investigations confirms that there are no significant barriers to the compounds development. Melting point of Beta sitosterol was determined using Thiele"s tube technique. Drug-excipients compatibility was carried out using Fourier-transform infrared spectroscopy, it was found that there are no incompatibilities between the drug and the excipients.
Method of preparation:
Beta sitosterol nanoparticles were prepared using eudragit RL100 and Poloxamer 407 as a stabilizer. Drug and polymer are taken in ratio 1:10 as this ratio shows more stability and no flocculation or sedimentation is been observed, also the required size to produce nanogel is obtained by this ratio. So nanoparticles were prepared for 1.10 drug to polymer ratio by nanoprecipitation method. The gel is been prepared by dispersion method by dispersing carbopol 934 in water for 2 hours for swelling. Once the carbopol is been swelled it is been kept on magnetic stirrer for stirring and the prescribed amount of nanoparticles dispersion or the separated nanoparticles is been added in the carbopol mixture, along with it propylene glycol which acts as the penetration enhancer and glycerin which acts as the humectant and viscosity modifier is ben added into the mixture. pH is been maintained using triethanolamine. 0.5% 1% 1.5% 2% Propylene glycol 10 ml 10 ml 10 ml 10 ml Glycerin 30 ml 30 ml 30 ml 30 ml
Physical characteristics:
The prepared nanogel formulations were inspected visually for their color. Appearance and consistency. Table no 2 tells about the physical characteristics. [1, 2] pH determination:
The pH values of 1% aqueous solutions of the prepared nanogels were measured by a pH meter (Digital pH meter). Refer Table no 3. [1, 2] Viscosity study:
The viscosity of the formulated batches was determined using a Brookfield viscometer with spindle 64 at 10 rpm. The assembly was connected to a thermostatically controlled circulating water bath maintained at 25˚C. The formulation whose viscosity was determined was
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[83] www.ajprd.com/AJPRD added to a beaker covered with a thermostatic jacket. The spindle was allowed to move freshly into the nanogel and the reading was noted. The Table no 4 tells about the viscosities of the four formulations. [1, 2] Extrudability study:
After gels were set in the container the formulations were filled in the collapsible tube. The extrudability of the formulation was determined in terms of weight in grams required to extrude a 0.5 cm ribbon gel in 10 seconds. [1, 2] Spreadability coefficient:
It consists of a wooden block which is attached to a pulley at one end. Spreading coefficient is measured on the basis of "slip" and "drag" characteristics of nanogel. A ground glass slide is fixed on the wooden block. An excess of nanogel under study was placed on the glass slide. The nanogel formulation was sandwitched between the two slides having the same dimensions that of fixed ground slide. The weight of 100 grams was placed on the top of the two slides for few seconds to provide uniform film of nanogel between the two slides.
A measured quantity of weight was placed in the pan attached to pulley with the help of hook. The time (in seconds) required by the top slide to cover a distance of 7 cm was noted. A shorter interval indicates better spreading coefficients. Refer Table no 6 for spreading coefficients. [1, 2] Drug Content determination:
The drug concentration in nanogel was measured by high performance thin layer chromatography. Beta Sitosterol content in nanogel was measured by dissolving known quantity of nanogel in Phosphate buffer (pH-7.4) by sonication. Area under curve was measured after suitable dilution at 550 nm in HPTLC. [5] In vitro drug release:
The in-vitro drug release studies were carried out using Franz diffusion cell. The formulation was applied on dialysis membrane which was placed between the donor and receptor compartment of the franz diffusion cell. The temperature of the cell was maintained at 37˚C by circulation jacket. This whole assembly was kept on a magnetic stirrer and the solution was stirred continuously using a magnetic bead. A similar blank set was run simultaneously as a control. Sample 5 ml was withdrawn at suitable time intervals and replaced with equal amounts of fresh dissolution media. Samples were analysed chromatographically at 550 nm and % drug release and control was used as the actual reading in each case. % drug release of each is shown in table no 8. [1, 2] Drug release kinetics [9, 10] Several drug release data on mathematical models can be obtained, hence drug release profile can be correlated with drug release kinetic models.
Zero order release kinetics
According to the principles of pharmacokinetics, drug release from the dosage form can be represented by the below equation
Co -Ct = K 0 t ………….. Eq.1
Ct= Co + K 0 t……………..Eq.2
Ct is the % amount of drug released at time t, C0 is the% CR drug at time t=0 K 0 is the zero order rate constant
Graph is plotted against % cumulative drug release vs. time.
First order release kinetics
The release of drug which follows first order kinetics is given below, it is the first order process whose rate is directly proportional to the concentration of drug undergoing reaction
Log C= log C 0 -K 1 t/ 2.303…………..Eq.3 K 1 is the first order rate equation expressed in time -1 or per hour. C 0 is the initial concentration of drug C is the percent of drug remaining at time t Graph is obtained by log % of CR vs. Time.
Higuchi model
Today it is considered as one of widely used and most well-known controlled release equation, which is represented below
Q = K H × t ½ …………Eq.4 K H is the Higuchi constant
Graph is plotted as %CR vs. square root of time
Korsmeyer peppas
Once it has been ascertained that the prime mechanism of drug release is diffusion controlled from Higuchi plot then it comes the release of drug follows which type of diffusion, to understand the dissolution mechanisms from the matrix the release data were fitted using the empirical equation. Graph is plotted log % CDR vs log time in hours
Hixson-Crowell model
The Hixon-Crowell cube root law describes the release from systems where there is a change in surface area and diameter of particles or tablets. Hence, particles of regular area are proportional to cube root of its volume. The relationship between the time and drug release can be described as 
In-vitro antibacterial activity:
Cup plate method is been used for studying various bacterial species. Muller Hinton agar medium is been used for the study. Make a saline solution and add loop of bacterial species in each of it. Add saline solution containing bacterial species and also add Muller Hinton agar in it which is allowed to cool and solidify. Later on make a disc using the cylinder and pour nanogel solution in the disc and incubate them for 24 hours and calculate area of inhibition.
RESULTS AND DISCUSSION
Fig 2: IR spectra of formulation
The above figure tells that there are no incompatibilities between the drug-excipients. It shows the presence of various functional groups like C-H stretching, C=O shows the presence of carboxylic acids and S=O shows the presence of sulfones, sulfates and sulfonamides.
Physical Appearance:
F1, F2, F3, F4 formulations show clear white appearance, all the 4 formulations were homogenous and free of grittiness The pH values of all prepared formulations were ranged between 6.40-6.84 which is been shown in (Table no 3) which is considerable to avoid the skin irritation of the skin after application. The measurement of viscosity of the prepared nanogel was done using the Brookfield viscometer F2 formulation showed better viscosity as compared to other formulations. 
Extrudability studies:
The extrudability studies is been determined and F2 Formulation showed better results that is 0.5 cm of ribbon is been extrude in 10 seconds from the collapsible tube. 
Spreadability coefficient:
The spreadability of various concentrations of carbopol 934 is been, out of which F2 showed better spreadability than the other formulations. 
Drug Content determination:
The drug content of Beta Sitosterol from its various nanogel formulations are represented in the (Table no 7) F2 and F3 showed better drug content as compared to other formulations. The percent drug content of these formulations was 95.06% and 94.11% respectively.
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[85] www.ajprd.com/AJPRD In-vitro diffusion study:
The in-vitro release profiles of Beta Sitosterol from various nanogel formulations are represented in (Table  no 8 For the first order release kinetics the graph is been plotted against log % Cumulative release vs. Time.
Fig 7: First order release kinetics
For the Higuchi model the graph is been plotted against % Cumulative release vs. Square root of time.
Fig 8: Higuchi Model
For Korsmeyer peppar graph is been plotted as log %CDR vs log time in hours. From the above drug release kinetics it was found that it follows Hixon-Crowell model of drug release kinetics as the value of R 2 was found to be near 1 that is 0.953. 
CONCLUSION:
Nanogel of Beta Sitosterol is been prepared which shows a good drug release, increased bioavailability of medium to moderate water soluble drugs. Nanogels is been helpful in providing the better action or efficacy of the drug due to its small particle size, as less the particle size the more is the surface area and hence more is the action. It also becomes a solution for encapsulating the hydrophobic drug in water soluble gel base for long term stability.
FUTURE PROSPECTIVE:
Nanogel containing beta sitosterol is been prepared and proved for In-vitro anti-bacterial activity. Anti-cancer activity will be done using animal study and proved in future.
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